Catherine Green
I head the Chromosome Dynamics group, where we study the processes of DNA replication and DNA repair to understand the causes and consequences of somatic mutations during the human lifespan.
I also head the Chromosome Dynamics Core Facility at the Wellcome Centre for Human Genetics, which provides bespoke chromosome and cell analysis services for scientists in the centre, as well as for the University of Oxford, and externally; and the Flow Cytometry Facility which supports FACS provision in the centre.
I am a Senior Research Fellow at Exeter College, Oxford, and also Head the Clinical BioManufacturing Facility for the NDM.
Recent publications
-
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Journal article
Barrett JR. et al, (2021), Nature Medicine, 27, 279 - 288
-
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Journal article
Ewer KJ. et al, (2021), Nature Medicine, 27, 270 - 278
-
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Journal article
Voysey M. et al, (2021), The Lancet, 397, 99 - 111
-
A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity.
Journal article
Nelson L. et al, (2020), Nature communications, 11
-
CRISPR-Cas9 Causes Chromosomal Instability and Rearrangements in Cancer Cell Lines, Detectable by Cytogenetic Methods.
Journal article
Rayner E. et al, (2019), The CRISPR journal